West Pharmaceutical Services, Inc. (WST)
West Pharmaceutical Services, Inc. EBITDA 2008–2025
West Pharmaceutical Services, Inc. annual/quarterly ebitda history and growth rate from 2009 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- West Pharmaceutical Services, Inc. ebitda for the quarter ending March 31, 2026 was 222.3 M, a 51.22% increase year-over-year.
- West Pharmaceutical Services, Inc. ebitda for the twelve months ending March 31, 2026 was 775.0 M.
- West Pharmaceutical Services, Inc. annual ebitda for 2025 was 756.3 M, a 4.27% increase from 2024.
- West Pharmaceutical Services, Inc. annual ebitda for 2024 was 725.3 M, a 10.82% decrease from 2023.
- West Pharmaceutical Services, Inc. annual ebitda for 2023 was 813.3 M, a 4.83% decrease from 2022.
- West Pharmaceutical Services, Inc. annual ebitda for 2022 was 854.6 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
West Pharmaceutical Services, Inc. EBITDA — FAQ
West Pharmaceutical Services, Inc. (WST) ebitda over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WST's ebitda history?
The chart and table above show West Pharmaceutical Services, Inc.'s ebitda by year and by quarter, including the growth rate.